Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-04-002307
Filing Date
2004-06-14
Accepted
2004-06-14 10:03:04
Documents
1
Period of Report
2004-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 3545
  Complete submission text file 0001005477-04-002307.txt   5499
Mailing Address FOUR SCIENCE PARK NEW HAVEN CT 06511
Business Address 4 SCIENCE PARK NEW HAVEN CT 06511 2034984210
VION PHARMACEUTICALS INC (Issuer) CIK: 0000944522 (see all company filings)

EIN.: 133671221 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ALFACELL CORP 225 BELLEVILLE AVE BLOOMFIELD NJ 07003
Business Address C/O ALFACELL CORP 225 BELLEVILLE AVE BLOOMFIELD NJ 07003 9737488082
CARTER STEPHEN (Reporting) CIK: 0001135217 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26534 | Film No.: 04859933